Molecular Partners
MOLN
8 hedge funds and large institutions have $6.18M invested in Molecular Partners in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
61% more capital invested
Capital invested by funds: $3.83M → $6.18M (+$2.35M)
0% more funds holding
Funds holding: 8 → 8 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.26% less ownership
Funds ownership: 2.6% → 2.35% (-0.26%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$48.5K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$14.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
-$456K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$6K |
MOLN Hedge Fund Activity: Q2 2024 in Review
8 of the 6,934 institutional investors tracked by Wall St. Rank reported a position in Molecular Partners (MOLN) for Q2 2024, worth a combined $6.18M — up 61% from $3.83M a quarter earlier.
Fund positioning in MOLN was balanced in Q2 2024: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Old Mission Capital, opening a new position worth an estimated $48.5K. The largest seller was Tang Capital Management, cutting an estimated $456K.
- 8 institutional investors held Molecular Partners (MOLN) as of Q2 2024, unchanged from Q1 2024.
- Funds reported $6.18M of Molecular Partners stock for Q2 2024, up 61% quarter-over-quarter.
- 1 fund opened new Molecular Partners positions in Q2 2024 and 1 closed out, a net change of 0 holders.
- The largest Molecular Partners buyer in Q2 2024 was Old Mission Capital, an estimated $48.5K added.
- The largest Molecular Partners seller in Q2 2024 was Tang Capital Management, an estimated $456K sold.
Based on aggregated 13F filings for Q2 2024.